Effects of bufalin and related cardiotonic steroids in the neuromuscular junction.
D000818:Animals; D002018:Bufanolides / Q000494:pharmacology*; D002297:Cardanolides / Q000494:pharmacology*; D002802:Cholinesterases / Q000378:metabolism; D003714:Denervation; D003964:Diaphragm / Q000187:drug effects; D004789:Enzyme Activation; D066298:In Vitro Techniques; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D009467:Neuromuscular Depolarizing Agents; D009469:Neuromuscular Junction / Q000187:drug effects*; D010042:Ouabain / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D051381:Rats; D012964:Sodium / Q000494:pharmacology; D013390:Succinylcholine / Q000037:antagonists & inhibitors; D014403:Tubocurarine / Q000037:antagonists & inhibitors
D002018:Bufanolides; D002297:Cardanolides; D009467:Neuromuscular Depolarizing Agents; D010042:Ouabain; D012964:Sodium; D010830:Physostigmine; D002802:Cholinesterases; D008274:Magnesium; D013390:Succinylcholine; D011188:Potassium; D014403:Tubocurarine